Related references
Note: Only part of the references are listed.T Cell Epitope Predictions
Bjoern Peters et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms
Inaki Etxeberria et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non-Small Cell Lung Cancer
Qingzhu Jia et al.
ADVANCED SCIENCE (2020)
Orthotopic T-Cell Receptor Replacement-An Enabler for TCR-Based Therapies
Kilian Schober et al.
CELLS (2020)
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
Junyun Lai et al.
NATURE IMMUNOLOGY (2020)
Systemic dysfunction and plasticity of the immune macroenvironment in cancer models
Breanna M. Allen et al.
NATURE MEDICINE (2020)
Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma
Maike Effern et al.
IMMUNITY (2020)
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Vid Leko et al.
CANCER CELL (2020)
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K. Wells et al.
CELL (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
Sebastian P. Haen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
Sri Krishna et al.
SCIENCE (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy
Ramon I. Klein Geltink et al.
NATURE METABOLISM (2020)
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. Van der Leun et al.
NATURE REVIEWS CANCER (2020)
Deciphering CD4+ T cell specificity using novel MHC-TCR chimeric receptors
Jan Kisielow et al.
NATURE IMMUNOLOGY (2019)
T cell antigen discovery via signaling and antigen-presenting bifunctional receptors
Alok Joglekar et al.
NATURE METHODS (2019)
T cell antigen discovery via trogocytosis
Guideng Li et al.
NATURE METHODS (2019)
Mechanisms of resistance to CAR T cell therapy
Nirali N. Shah et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
Gal Cafri et al.
NATURE COMMUNICATIONS (2019)
Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
Lili Ren et al.
ONCOIMMUNOLOGY (2019)
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
Kellie N. Smith et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Induction of neoantigen-reactive T cells from healthy donors
Muhammad Ali et al.
NATURE PROTOCOLS (2019)
Determinants for Neoantigen Identification
Andrea Garcia-Garijo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells
Sunil Kumar Saini et al.
SCIENCE IMMUNOLOGY (2019)
T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes
Tomasz Kula et al.
CELL (2019)
Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood
Songming Peng et al.
CELL REPORTS (2019)
Endogenous T cells prevent tumor immune escape following adoptive T cell therapy
Scott R. Walsh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Predicting HLA class II antigen presentation through integrated deep learning
Binbin Chen et al.
NATURE BIOTECHNOLOGY (2019)
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
Kroopa Joshi et al.
NATURE MEDICINE (2019)
Rapid selection and identification of functional CD8+ T cell epitopes from large peptide-coding libraries
Govinda Sharma et al.
NATURE COMMUNICATIONS (2019)
Safety and Tolerability of Adoptive Cell Therapy in Cancer
Benita Wolf et al.
DRUG SAFETY (2019)
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Brendan Bulik-Sullivan et al.
NATURE BIOTECHNOLOGY (2019)
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
Wouter Scheper et al.
NATURE MEDICINE (2019)
Defining 'T cell exhaustion'
Christian U. Blank et al.
NATURE REVIEWS IMMUNOLOGY (2019)
HLA and proteasome expression body map
Sebastian Boegel et al.
BMC MEDICAL GENOMICS (2018)
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
Marvin H. Gee et al.
CELL (2018)
Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell Populations
Cristina Rius et al.
JOURNAL OF IMMUNOLOGY (2018)
An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors
Yong-Chen Lu et al.
MOLECULAR THERAPY (2018)
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
Nikolaos Zacharakis et al.
NATURE MEDICINE (2018)
Bispecific antibodies for cancer therapy: A review
Anuradha Krishnamurthy et al.
PHARMACOLOGY & THERAPEUTICS (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen et al.
NATURE COMMUNICATIONS (2018)
Current Concepts of Antigen Cross-Presentation
Maria Embgenbroich et al.
FRONTIERS IN IMMUNOLOGY (2018)
Single Cell T Cell Receptor Sequencing: Techniques and Future Challenges
Marco De Simone et al.
FRONTIERS IN IMMUNOLOGY (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment
Yien Ning Sophia Wong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth et al.
NATURE (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: Doublet Technology
Estefania Garcia-Guerrero et al.
FRONTIERS IN IMMUNOLOGY (2018)
High-throughput determination of the antigen specificities of T cell receptors in single cells
Shu-Qi Zhang et al.
NATURE BIOTECHNOLOGY (2018)
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
Maria Parkhurst et al.
CLINICAL CANCER RESEARCH (2017)
Cell death and thymic tolerance
Stephen R. Daley et al.
IMMUNOLOGICAL REVIEWS (2017)
T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
Robert Sackstein et al.
LABORATORY INVESTIGATION (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
Sanja Stevanovic et al.
SCIENCE (2017)
The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
Terhi Karpanen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
Yasmine Assadipour et al.
CLINICAL CANCER RESEARCH (2017)
Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy
Sarita M. Fernandez-Poma et al.
CANCER RESEARCH (2017)
Evolution of MHC-based technologies used for detection of antigen-responsive T cells
Amalie Kai Bentzen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
A High-avidity WT1-reactive T-Cell Receptor Mediates Recognition of Peptide and Processed Antigen but not Naturally Occurring WT1-positive Tumor Cells
Adnan Jaigirdar et al.
JOURNAL OF IMMUNOTHERAPY (2016)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani-Sternberg et al.
NATURE COMMUNICATIONS (2016)
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
Anna Pasetto et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Translational Implications of Tumor Heterogeneity
Mariam Jamal-Hanjani et al.
CLINICAL CANCER RESEARCH (2015)
More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers
Garry Dolton et al.
IMMUNOLOGY (2015)
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cyrille J. Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
Targeting T cell metabolism for therapy
David O'Sullivan et al.
TRENDS IN IMMUNOLOGY (2015)
Cancer vaccines
Lisa H. Butterfield
BMJ-BRITISH MEDICAL JOURNAL (2015)
Cancer vaccines
Lisa H. Butterfield
BMJ-BRITISH MEDICAL JOURNAL (2015)
Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing
Miran Jang et al.
OncoImmunology (2015)
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma
Carsten Linnemann et al.
NATURE MEDICINE (2015)
Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing
Mark Klinger et al.
PLOS ONE (2015)
Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells
G. Dolton et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
gamma delta T cells for cancer immunotherapy A systematic review of clinical trials
Jonathan P. H. Fisher et al.
ONCOIMMUNOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P. Linette et al.
BLOOD (2013)
Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
Yong-Chen Lu et al.
JOURNAL OF IMMUNOLOGY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
Combining Next-Generation Sequencing and Immune Assays: A Novel Method for Identification of Antigen-Specific T Cells
Mark Klinger et al.
PLOS ONE (2013)
Cytometry by Time-of-Flight Shows Combinatorial Cytokine Expression and Virus-Specific Cell Niches within a Continuum of CD8+ T Cell Phenotypes
Evan W. Newell et al.
IMMUNITY (2012)
The determinants of tumour immunogenicity
Thomas Blankenstein et al.
NATURE REVIEWS CANCER (2012)
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Jacques Neefjes et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
Takashi Inozume et al.
JOURNAL OF IMMUNOTHERAPY (2010)
T Cell Activation
Jennifer E. Smith-Garvin et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers
Sine Reker Hadrup et al.
NATURE METHODS (2009)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties
Bruno Laugel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities
Matthias Wolfl et al.
BLOOD (2007)
Design and use of conditional MHC class I ligands
M Toebes et al.
NATURE MEDICINE (2006)
Generation of peptide-MHC class I complexes through UV-mediated ligand exchange
Boris Rodenko et al.
NATURE PROTOCOLS (2006)
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
V Lennerz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
What is trogocytosis and what is its purpose?
E Joly et al.
NATURE IMMUNOLOGY (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells
MV Dhodapkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA
A Heiser et al.
JOURNAL OF IMMUNOLOGY (2001)